| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/26/2001 | WO2001053294A1 Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one |
| 07/26/2001 | WO2001053293A1 Pseudopolymorph of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one |
| 07/26/2001 | WO2001053290A1 Cell division inhibitors and process for producing the same |
| 07/26/2001 | WO2001053289A1 Anticancer compound and enantiomer separation method useful for synthesizing said compound |
| 07/26/2001 | WO2001053285A1 Food product and process |
| 07/26/2001 | WO2001053282A1 Semi-synthetic taxanes with antitumor and antiangiogenetic activities |
| 07/26/2001 | WO2001053280A1 Substituted phenylamidines medicaments containing said compounds and method for production thereof |
| 07/26/2001 | WO2001053279A1 Urea compounds as inhibitors for vla-4 |
| 07/26/2001 | WO2001053274A1 Amide compounds for inhibiting protein kinases |
| 07/26/2001 | WO2001053271A1 Imidazole compounds and their use as adenosine deaminase inhibitors |
| 07/26/2001 | WO2001053268A2 Indazole compounds, pharmaceutical compositions, and their use for mediating or inhibiting cell proliferation |
| 07/26/2001 | WO2001053266A1 Therapeutic morpholino-substituted compounds |
| 07/26/2001 | WO2001053263A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | WO2001053262A1 Alpha v integrin receptor antagonists |
| 07/26/2001 | WO2001053261A1 Substituted glutarimides and use thereof il-12 production inhibitors |
| 07/26/2001 | WO2001053256A1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same |
| 07/26/2001 | WO2001053254A1 Calcilytic compounds |
| 07/26/2001 | WO2001052904A2 Pharmaceutical compositions and methods of treatment based on vegf antisense oligonucleotides |
| 07/26/2001 | WO2001052893A1 Composition consisting of an active ingredient and a therapeutically active delivery system, especially in the treatment of angiogenesis |
| 07/26/2001 | WO2001052892A2 Jak/stat pathway inhibitors and the uses thereof |
| 07/26/2001 | WO2001052889A1 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers |
| 07/26/2001 | WO2001052884A1 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this method |
| 07/26/2001 | WO2001052882A1 Combination of temozolomide and pegylated interferon-alpha for treating cancer |
| 07/26/2001 | WO2001052881A1 Interferon-alpha use in the treatment of ewing's family of tumors |
| 07/26/2001 | WO2001052874A2 Intra-tumoral administration of il-12 encoding nucleic acid molecules |
| 07/26/2001 | WO2001052868A1 Combinations for treating neoplasms |
| 07/26/2001 | WO2001052865A1 Antisense modulation of glycogen synthase kinase 3 alpha expression |
| 07/26/2001 | WO2001052863A1 Antisense modulation of mekk2 expression |
| 07/26/2001 | WO2001052838A1 Purifying polyoxyethylated castor oils with activated charcoal and pharmaceutical formulations thereof |
| 07/26/2001 | WO2001052837A2 Use of at least a fatty ester for preparing a composition designed to inhibit 5-$g(a)-reductase activity, in pharmacology, in particular dermatology, in cosmetics and as food additive |
| 07/26/2001 | WO2001052828A2 Glutamine prevention of delayed-onset irinotecan-induced diarrhea |
| 07/26/2001 | WO2001052826A2 Novel podophyllotoxin compositions |
| 07/26/2001 | WO2001052791A2 Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents |
| 07/26/2001 | WO2001052789A2 PAX8-PPARη NUCLEIC ACID MOLECULES AND POLYPEPTIDES AND USES THEREOF |
| 07/26/2001 | WO2001052746A1 Versatile hydrophilic dyes |
| 07/26/2001 | WO2001052743A1 Tunable indocyanine dyes for biomedical applications |
| 07/26/2001 | WO2001052664A1 Immune modulation with death receptor-induced apoptosis |
| 07/26/2001 | WO2001034206A8 Nucleic acid-containing complex |
| 07/26/2001 | WO2001021137A8 Extracts of orange peel for prevention and treatment of cancer |
| 07/26/2001 | WO2001017543A3 Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| 07/26/2001 | WO2001017535A3 Enriched fraction from a porcine liver extract for treating human diseases |
| 07/26/2001 | WO2001014415A3 Egfh2 genes and gene products |
| 07/26/2001 | WO2001010902A8 Nucleoc acids and secreted polypeptides encoded thereby |
| 07/26/2001 | WO2001008663A3 Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
| 07/26/2001 | WO2001007058A3 Parenteral cisplatin emulsion |
| 07/26/2001 | WO2001005372A3 A liposome composition having resistance to freeze/thaw damage |
| 07/26/2001 | WO2001001748A3 Peptide compounds that bind her2 |
| 07/26/2001 | WO2001000784A3 Compound derived from an offset orf of the ice gene |
| 07/26/2001 | WO2000078939A3 Vectors for the treatment of tumors by gene therapy |
| 07/26/2001 | WO2000078803A3 Use of eif4e binding agents in therapy |
| 07/26/2001 | WO2000074711A3 10-formyltetrahydrofolate dehydrogenase as therapeutical agent |
| 07/26/2001 | WO2000070341A3 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
| 07/26/2001 | WO2000069915A3 COMBINED APPROACH TO TREATMENT OF CANCER WITH hCG VACCINES |
| 07/26/2001 | WO2000066156A8 Death domain containing receptor 5 |
| 07/26/2001 | WO2000060079A9 New members of tnf and tnfr families |
| 07/26/2001 | WO2000056342A3 Use of stabilised oligonucleotides for preparing a medicine with antitumour activity |
| 07/26/2001 | WO2000041566A9 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/26/2001 | WO2000017361A3 Interferon-epsilon |
| 07/26/2001 | US20010009919 Tris benzimidazoles; fungicides, anticarcinogenic agents, enzyme inhibitor |
| 07/26/2001 | US20010009917 Reducing associated adverse effects; 5-lipoxygenase inhibitor, useful in treatment of conditions related to elevated leukotriene levels |
| 07/26/2001 | US20010009914 Acridone-derived compounds useful as antineoplastic and antiretroviral agents |
| 07/26/2001 | US20010009903 Roasting process using far infrared radiation, microorganism fermentation to produce peroxide lipid thereby improving antitumor activity |
| 07/26/2001 | US20010009680 Such as various cancers, by administering low molecular weight compounds of following properties: extractable from bile of an animal, stimulates monocytes and macrophages, modulates tumor necrosis factor production, not endotoxin |
| 07/26/2001 | US20010009656 For treating solid mass tumors via catheter delivery, comprising a biocompatible polymer, a biocompatible solvent and a water insoluble radioisotope of given radioactive content |
| 07/26/2001 | DE19961141A1 Pharmazeutische Zusammensetzung aus Spinnengiften sowie deren Herstellung und Verwendung zur Behandlung von Tumorerkrankungen The pharmaceutical composition of spider venoms as well as their preparation and use for the treatment of tumor diseases |
| 07/26/2001 | DE19953167A1 Mit TRP-Proteinen verwandtes Protein MTR1 und dieses codierende DNA-Sequenz With TRP proteins related protein MTR1 and this DNA sequence encoding |
| 07/26/2001 | DE10100779A1 Formulierung Formulation |
| 07/26/2001 | DE10002510A1 New phenylamidine compounds are useful for the treatment of thrombosis, cerebrovascular disorders, heart infarction, arteriosclerosis, osteoporosis, tumor metastasis, shock and diabetes |
| 07/26/2001 | DE10002509A1 New substituted glutarimide derivatives are IL-12 antagonists, are useful as immunomodulators and for the treatment of angiopathy, hematological or oncological disorders |
| 07/26/2001 | CA2398695A1 Chondromodulin-i related peptide |
| 07/26/2001 | CA2398343A1 Virus strains for the oncolytic treatment of cancer |
| 07/26/2001 | CA2398256A1 Methods for detecting cancer of the central nervous system |
| 07/26/2001 | CA2398086A1 Composition consisting of an active ingredient and a therapeutically active delivery system, especially in the treatment of angiogenesis |
| 07/26/2001 | CA2398061A1 Substituted glutarimides and their use as inhibitors of il-12 production |
| 07/26/2001 | CA2397946A1 Lipid metabolism enzymes |
| 07/26/2001 | CA2397919A1 Pharmaceutical compositions and methods of treatment based on vegf antisense oligonucleotides |
| 07/26/2001 | CA2397871A1 Novel podophyllotoxin compositions |
| 07/26/2001 | CA2397848A1 Purifying polyoxyethylated castor oils with activated charcoal and pharmaceutical formulations thereof |
| 07/26/2001 | CA2397802A1 Calcilytic compounds |
| 07/26/2001 | CA2397793A1 Combination of temozolomide and pegylated interferon-alpha for treating cancer |
| 07/26/2001 | CA2397774A1 Jak/stat pathway inhibitors and the uses thereof |
| 07/26/2001 | CA2397729A1 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this method |
| 07/26/2001 | CA2397665A1 Alpha v integrin receptor antagonists |
| 07/26/2001 | CA2397633A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | CA2397598A1 Combinations for treating neoplasms |
| 07/26/2001 | CA2397597A1 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof |
| 07/26/2001 | CA2397571A1 Apoptin-associating protein |
| 07/26/2001 | CA2397565A1 Food product and process |
| 07/26/2001 | CA2397533A1 Substituted phenylamidines, pharmaceutical compositions containing these compounds and processes for preparation thereof |
| 07/26/2001 | CA2397531A1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same |
| 07/26/2001 | CA2397205A1 Antisense modulation of macrophage migration inhibitory factor expression |
| 07/26/2001 | CA2397202A1 Antisense modulation of glycogen synthase kinase 3 alpha expression |
| 07/26/2001 | CA2396979A1 Immune modulation with death receptor-induced apoptosis |
| 07/26/2001 | CA2396935A1 Phosphatases |
| 07/26/2001 | CA2395855A1 Recombinant flaviviruses and methods of use thereof |
| 07/26/2001 | CA2395770A1 Methods and materials relating to novel von willebrand/thrombospondin-like polypeptides and polynucleotides |
| 07/26/2001 | CA2395054A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | CA2394703A1 Amide compounds for inhibiting protein kinases |
| 07/26/2001 | CA2388885A1 Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| 07/26/2001 | CA2365610A1 Compositions and methods for the treatment of tumor |